223 related articles for article (PubMed ID: 24228126)
41. Can K-ras-mutated atypical adenomatous hyperplasia be another precursor lesion for mucinous bronchioloalveolar carcinoma?
Garfield D
Am J Clin Pathol; 2008 Aug; 130(2):315-6; author reply 316. PubMed ID: 18697292
[No Abstract] [Full Text] [Related]
42. Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: immunohistochemical studies and mutation analysis of the p53 gene.
Sato K; Ueda Y; Shikata H; Katsuda S
Pathol Res Pract; 2006; 202(10):751-6. PubMed ID: 16959434
[TBL] [Abstract][Full Text] [Related]
43. Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung.
Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
Mod Pathol; 2007 Sep; 20(9):967-73. PubMed ID: 17618248
[TBL] [Abstract][Full Text] [Related]
44. [Congenital cystic adenomatoid malformations of the lung: diagnosis, treatment, pathophysiological hypothesis].
Lezmi G; Hadchouel A; Khen-Dunlop N; Vibhushan S; Benachi A; Delacourt C
Rev Pneumol Clin; 2013 Aug; 69(4):190-7. PubMed ID: 23850268
[TBL] [Abstract][Full Text] [Related]
45. Cytogenetic and p53 profiles in congenital cystic adenomatoid malformation: insights into its relationship with pleuropulmonary blastoma.
Vargas SO; Korpershoek E; Kozakewich HP; de Krijger RR; Fletcher JA; Perez-Atayde AR
Pediatr Dev Pathol; 2006; 9(3):190-5. PubMed ID: 16944975
[TBL] [Abstract][Full Text] [Related]
46. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.
Khalid A; Zahid M; Finkelstein SD; LeBlanc JK; Kaushik N; Ahmad N; Brugge WR; Edmundowicz SA; Hawes RH; McGrath KM
Gastrointest Endosc; 2009 May; 69(6):1095-102. PubMed ID: 19152896
[TBL] [Abstract][Full Text] [Related]
47. Bronchioloalveolar adenocarcinoma and pulmonary langerhans cell histiocytosis in a patient with MUTYH-associated polyposis.
von der Thüsen JH; van de Wetering MD; Westermann AM; Heideman DA; Thunnissen E
J Clin Oncol; 2011 Mar; 29(8):e188-90. PubMed ID: 21189386
[No Abstract] [Full Text] [Related]
48. KRAS mutation positive mucinous adenocarcinoma originating in mature ovarian teratoma: case report and review of literature.
Hershkovitz D; Vlodavsky E; Simon E; Ben-Izhak O
Pathol Int; 2013 Dec; 63(12):611-4. PubMed ID: 24422958
[TBL] [Abstract][Full Text] [Related]
49. Laser microdissection allows detection of abnormal gene expression in cystic adenomatoid malformation of the lung.
Jancelewicz T; Nobuhara K; Hawgood S
J Pediatr Surg; 2008 Jun; 43(6):1044-51. PubMed ID: 18558180
[TBL] [Abstract][Full Text] [Related]
50. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
Sakamoto H; Shimizu J; Horio Y; Ueda R; Takahashi T; Mitsudomi T; Yatabe Y
J Pathol; 2007 Jul; 212(3):287-94. PubMed ID: 17534846
[TBL] [Abstract][Full Text] [Related]
51. Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.
Mackinnon AC; Tretiakova M; Henderson L; Mehta RG; Yan BC; Joseph L; Krausz T; Husain AN; Reid ME; Salgia R
J Clin Pathol; 2011 Jan; 64(1):16-24. PubMed ID: 21045234
[TBL] [Abstract][Full Text] [Related]
52. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
Miller VA; Riely GJ; Zakowski MF; Li AR; Patel JD; Heelan RT; Kris MG; Sandler AB; Carbone DP; Tsao A; Herbst RS; Heller G; Ladanyi M; Pao W; Johnson DH
J Clin Oncol; 2008 Mar; 26(9):1472-8. PubMed ID: 18349398
[TBL] [Abstract][Full Text] [Related]
53. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features?
Glynn C; Zakowski MF; Ginsberg MS
J Thorac Oncol; 2010 Mar; 5(3):344-8. PubMed ID: 20087229
[TBL] [Abstract][Full Text] [Related]
54. A case report of an unusual non-mucinous papillary variant of CPAM type 1 with KRAS mutations.
Koopman T; Rottier BL; Ter Elst A; Timens W
BMC Pulm Med; 2020 Feb; 20(1):52. PubMed ID: 32093717
[TBL] [Abstract][Full Text] [Related]
55. Multifocal synchronous mucinous adenocarcinomas arising in congenital pulmonary airway malformation: a case report with molecular study.
Kim MY; Kang CH; Park SH
Histopathology; 2014 Dec; 65(6):926-32. PubMed ID: 25066006
[TBL] [Abstract][Full Text] [Related]
56. [A case of congenital cystic adenomatoid malformation of the lung in 18-year-old male].
Akiba T; Yamazaki Y; Yasukawa S; Yuno S; Yoshida T; Sakurai K
Nihon Kyobu Geka Gakkai Zasshi; 1992 Jan; 40(1):161-4. PubMed ID: 1564351
[TBL] [Abstract][Full Text] [Related]
57. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
58. Mucinous adenocarcinoma of the lung in association with congenital pulmonary airway malformation.
Summers RJ; Shehata BM; Bleacher JC; Stockwell C; Rapkin L
J Pediatr Surg; 2010 Nov; 45(11):2256-9. PubMed ID: 21034957
[TBL] [Abstract][Full Text] [Related]
59. Case report: Congenital cystic adenomatoid malformation of an entire lung in a 33-year-old man: a case report and review of the literature.
Khan NU; Jones MT; Greaves M
Br J Radiol; 2008 Nov; 81(971):e276-8. PubMed ID: 18941042
[TBL] [Abstract][Full Text] [Related]
60. A 75-year-old man with progressive bronchioalveolar carcinoma.
Baikadi M; Lovly C; Horn L; Reckamp KL; Noonan K; Laskin J; Morris GJ
Semin Oncol; 2013 Feb; 40(1):e1-8. PubMed ID: 23391120
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
